|
EP2971006A2
|
|
Reproducible method for testis-mediated genetic modification (tgm) and sperm-mediated genetic modification (sgm)
|
|
CN105051204A
|
|
Site-specific enzymes and methods of use
|
|
AU2012352083A1
|
|
TRPC4 modulators for use in the treatment or prevention of pain
|
|
WO2012158986A2
|
|
Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organisms
|
|
WO2012158985A2
|
|
Methods for site-specific genetic modification in spermatogonial stem cells using zinc finger nuclease (zfn) for the creation of model organisms
|
|
WO2012158982A2
|
|
Methods for transgenesis of spermatogonial stem cells (sscs) and organisms using transposon vectors
|
|
WO2012129198A1
|
|
Genetically modified rat models for obesity and diabetes
|
|
EP2467013A2
|
|
Genetically modified rat models for pain
|
|
EP2461672A2
|
|
Genetically modified rat models for drug metabolism
|
|
EP2460016A2
|
|
Genetically modified rat models for pharmacokinetics
|
|
EP2456876A2
|
|
Genetically modified rat models for cytokine-cytokine signaling pathways
|
|
EP2449112A1
|
|
Genetically modified rat models for severe combined immunodeficiency (scid)
|
|
WO2010124200A2
|
|
Genetically modified rat models for cancer
|
|
EP2401367A1
|
|
Hyperactive piggybac transposases
|
